1. Home
  2. GLAS vs CSTL Comparison

GLAS vs CSTL Comparison

Compare GLAS & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$7.85

Market Cap

836.9M

Sector

Health Care

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$34.70

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLAS
CSTL
Founded
N/A
2007
Country
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.9M
722.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
GLAS
CSTL
Price
$7.85
$34.70
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
562.5K
275.5K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
N/A
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$7.70
$17.72
52 Week High
$12.70
$44.28

Technical Indicators

Market Signals
Indicator
GLAS
CSTL
Relative Strength Index (RSI) 33.11 58.21
Support Level $7.70 $22.88
Resistance Level $8.41 $42.03
Average True Range (ATR) 0.42 1.44
MACD -0.02 0.01
Stochastic Oscillator 14.89 57.86

Price Performance

Historical Comparison
GLAS
CSTL

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: